Navigation Links
Le cardio pourrait être la clé pour soigner le cancer
Date:4/25/2013

AMSTERDAM, April 26, 2013 /PRNewswire/ --

D'après une étude unique au monde réalisée sur des souris, la pratique d'un exercice régulier réduit le risque de développer un cancer du foie, apportant ainsi un espoir pour les patients à risque de carcinome hépatocellulaire (CHC).

     (Logo: http://photos.prnewswire.com/prnh/20120728/551976)

Les recherches présentées lors de l'International Liver Congress™ 2013 comprenaient deux groupes de souris soumises à un régime alimentaire contrôlé riche en matières grasses et ensuite divisées en deux catégories : les sédentaires et celles soumises à des exercices physiques. [1] Ces dernières ont couru sur un tapis roulant 60 minutes par jour, 5 jours par semaine.

Après 32 semaines d'exercice régulier, 71 % des souris sous régime alimentaire contrôlé ont développé une tumeur plus large de 10 mm contre 100 % des souris sédentarisées. Le nombre moyen et le volume des tumeurs CHC par foie a également été réduit dans le groupe de souris soumises aux exercices réguliers par rapport au groupe de souris sédentarisées.

Le Professeur Jean-François Dufour, Conseiller Pédagogique à l'EASL (European Association for the study of liver) a déclaré que les résultats démontraient le bénéfice considérable de pratiquer un exercice régulier sur la prévention du CHC. L'exercice réduit le niveau de stéatose hépatique non alcoolique chez les souris ayant reçu un régime riche en matières grasses. Il a ainsi affirmé : « Nous savons que les styles de vie actuels, malsains, prédisposent les populations à la stéatose hépatiqu
'/>"/>

SOURCE The European Association for the Study of the Liver (EASL)
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Emory Cardiologists Arshed Quyyumi And Javed Butler Join Stemedica Cardiology Division Scientific Advisory Board
2. ChanTest Introduces the CardioChannelGram™ and SaVety Assessment
3. Cardiovascular Drug Delivery - Technologies, Markets and Companies - 2013 Report
4. Douglas Harrington, MD Addresses Select Group Of Physicians Regarding Latest Advances In Cardiovascular Risk Assessment
5. CardioWise™ Welcomes Geoffrey Dalbow as Chief Technology Officer
6. Infinata’s BioPharm Insight Gears Up for the 2013 American College of Cardiology Meeting with the Release of its Cardiovascular Diseases Report
7. Stephen Epstein, MD To Head Scientific & Medical Advisory Board For Stemedica’s Cardiology Division
8. Interventional Cardiology Devices Market is Expected to Reach USD 25.2 Billion Globally in 2018: Transparency Market Research
9. Cardiometabolic Health Congress Expert Faculty Evaluate the Clinical Implications of Newly FDA-Approved Treatment for Homozygous Familial Hypercholesterolemia
10. Cardium Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease
11. Micropharma Convenes Expert Roundtable on New Role for Probiotics in Cardiovascular Disease in time for National Cholesterol Education Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... -- Roka Bioscience, Inc. (NASDAQ: ROKA ), a molecular ... detection of foodborne pathogens,  today announced that Paul G. ... Lynch 2015 Health Care Conference on May 12 at 8:00am ... Wynn, Las Vegas NV. ... through the investor relations section of Roka Bioscience,s website at ...
(Date:5/5/2015)... 2015 Research and Markets ... of the "Separation Systems Market in ... Macromolecules which include protein, RNA, DNA ... broken into smaller molecules, during production of ... various advanced systems like centrifugation, liquid chromatography, ...
(Date:5/5/2015)... DIEGO , May 5, 2015  Renova™ ... for congestive heart failure and other chronic diseases, ... an independent analysis designed to reflect the healthcare ... time. This model will be used to characterize ... CHF, could have on those groups of patients ...
(Date:5/5/2015)... WASHINGTON, D.C., USA (PRWEB) May 05, 2015 ... export regulations covering a wide range of key photonics ... are hampering global competitiveness of U.S. industry. To help ... webinar on 12 May on the proposed ... governs the commodities covered by International Traffic in Arms ...
Breaking Biology Technology:Global Separation Systems Market in Biotechnology 2015-2019 - Trends and Forecasts for the $28 Billion Market 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4
... A2A Adenosine Receptor Agonist Approved for Use in Identifying ... ... Astellas Pharma US, Inc. today,announced the commercial availability of ... a pharmacologic,stress agent in radionuclide MPI -- a test that ...
... JOSEPH, Mich., June 24 GeneGo, Inc., ... that VTT has licensed,MetaCore(TM). VTT develops novel ... diagnostics. The focus is in investigating,mechanisms of ... and exploration of the mechanism of action ...
... 24 Pinnacle Biologics, a private,full-service pharmaceutical and ... an agreement with Chiltern International, Inc. for the,activities ... Europe., James R. Miller, President & CEO ... agreement represents a significant step in the,process of ...
Cached Biology Technology:Astellas Launches Lexiscan(TM) (Regadenoson) Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging (MPI) 2Astellas Launches Lexiscan(TM) (Regadenoson) Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging (MPI) 3VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo for Cancer Research and Diagnostics 2Pinnacle Biologics Announces Contract With Chiltern 2
(Date:4/8/2015)... N.C. , April 8, 2015  Infinisource, ... solutions and services, and Morpho, a leading supplier ... partnership to produce the market,s most advanced biometrically-enabled ... Infinisource,s iSolved NXG time clock is setting a ... and labor data for the small and mid-size ...
(Date:4/2/2015)... Germany , April 2, 2015 ... fingerprint tests DERMALOG by far outperforms the strongest ... always maintaining high accuracy, the system is capable ... Hence, the speed proves up to be ten ... faster than its runner-up performance.      ...
(Date:4/2/2015)... 2, 2015 According to preliminary ... to somewhat higher than 125 MSEK. This exceeds the ... 2014 that revenues for Q1 2015 would be in ... for Q4 2014. The operating result for the first ... complete interim report will as previously communicated be published ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2
... in partnership with Affymetrix, Inc., have designed a chip ... varieties and suggest ways to better manage them. By ... tissue of citrus ?genes that are associated with taste, ... information useful to researchers for rectifying existing problems and ...
... Dr. Peter Sarnow and a team of Stanford University scientists ... named miR-122, in order to replicate in cultured liver cells. ... amount of hepatitis C virus RNA was reduced by approximately ... potential to develop new antiviral agents against hepatitis C, the ...
... tiny viruses to build ultra-small "nanowire" structures for use ... few genes inside these viruses, the team was able ... a functional electronic device. , The goal of the ... and Yet-Ming Chiang, is to create batteries that cram ...
Cached Biology News:UCR researchers design chip that can improve citrus varieties 2UCR researchers design chip that can improve citrus varieties 3MIT researchers build tiny batteries with viruses 2MIT researchers build tiny batteries with viruses 3
The optional fixed lens, 105 mm, is for use with the VersaDoc imaging systems for imaging small samples at high resolution....
... The UltraClean Plant DNA Kit is ... total cellular DNA from plant cells and ... this kit replaces cumbersome DNA isolation procedures ... Using the UltraClean procedure, alcohol precipitation is ...
The sample holders for gels are used to hold gels in place in the multi-sample tray I, which is used with Molecular Imager FX imaging systems....
... Direct In Situ Apoptosis Detection ... situ by the direct TUNEL ... tagged with a directly labeled ... fluorescence staining for 40 samples ...
Biology Products: